Social Media Content Creators Driving Parallel Trade for Unapproved Slimming Drug

An underground market for unlicensed slimming medications is propelled by TikTok fitness influencers and vendors on communication apps, based on recent findings.

Investigational Drug Gaining Traction Online

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Viewers are urged to contact these profiles directly for source information, while also obtaining discount codes.

Active Commerce on Social Networks

Additionally, a flourishing trade exists on messaging services, where groups with numerous of participants share “before and after” photos, injection guides and assertions of rapid British shipping. Vendors promote the drug there before redirecting buyers to other platforms for purchases.

Learning About The Experimental Drug

This medication is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and glucagon. Early trials suggest it could help individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Medical Experts Voice Worries

However, doctors and chemists have cautions that the distribution of what is still an unlicensed medication in the UK is worrisome and could result in users injecting products of uncertain source.

Several professionals stated the demand for the experimental drug could be linked to the rising cost of approved slimming treatments such as Mounjaro.

Legal Status and Implementation

Marketing retatrutide on social media or Telegram is illegal in the UK, as it is an unapproved drug that cannot be promoted or distributed for human use under the British medical regulations.

Some content creators try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still breach pharmaceutical, marketing, and customer laws, potentially leading to penalties, legal action or prison.

Service Response and Content Removal

According to TikTok, the service has removed violative material and banned associated keywords and search suggestions. The company stated it was committed to maintaining the service safe and allocating resources in enhancing enforcement strategies.

Online Marketplace Operations

Investigations also found groups with up to nine thousand members selling retatrutide using Telegram's built-in discovery tool, which functions like a public directory. Typing “retatrutide” immediately displays channels with thousands of users, filled with photos of slimming results, positive reviews and detailed guides for mixing or injecting at residence.

Within moments of joining one community, a vendor posted WhatsApp details, where most purchases take place. The vendor provided an guidebook and promised shipping within two days. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one asked about weight, health issues or previous experience.

Item Details and Costs

Inside these groups, messages show black plastic parcels with postal service stickers, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at home with sterile water, or ready-to-use injectors usually priced at 160 pounds for 20mg. When asked how long a pen should last, vendors give contradictory responses ranging from a several days to “depends on your body”.

Platform Moderation and Safety Measures

A representative for the messaging service stated it regularly moderated harmful content on its service including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are administering materials they can’t verify. Even if the science behind retatrutide is sound, these online products may not include what they claim,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.

A medical professional of an online medical service connected the surge in interest to recent cost increases for approved weight-loss medications such as Mounjaro. “With prices rising, individuals are turning to social media. But counterfeit treatments are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she said.

Her staff has previously seen individuals injured by self-injection from unverified sources. “We recognize the frustration, but buying from messaging apps or WhatsApp is taking chances with your health,” stated Wyllie. “These materials could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this time no one can sell [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a company experimental substance not yet authorized … may expose patients to possibly significant health risks”.

Terri Davis
Terri Davis

Lena is a seasoned innovation consultant with over a decade of experience helping startups transform ideas into successful ventures.